HomeNewsDrug shortage

Drug Shortage

Jump to

Novartis India facing shortage of drug ‘Simulect’ used on kidney transplant patients

Simulect is an intravenous prescription drug that is used on transplant patients to ensure the body does not reject the new organ
US drug shortages as much a threat as an opportunity for Indian pharma

Falling margins even the extra demand created by the shortage may not bring cheer to them. But rival China may step into the breach
US drug shortages rekindle pharma recovery hopes

Drug shortages have increased in the US amid supply chain and manufacturing constraints. Domestic sales are growing too
US API import ban applies only to one drug: Biocon CMD

The US government‘s decision to not allow overseas pharmaceutical companies to import active pharmaceutical ingredient (API) applies to only one particular anti retroviral drug and is not a blanket ban, Biocon CMD Kiran Mazumdar-Shaw said.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Drug Shortage

Novartis India facing shortage of drug ‘Simulect’ used on kidney transplant patients

US drug shortages as much a threat as an opportunity for Indian pharma

US drug shortages rekindle pharma recovery hopes

US API import ban applies only to one drug: Biocon CMD